Squarepoint Ops LLC Alaunos Therapeutics, Inc. Transaction History

Squarepoint Ops LLC

$62.8 Billion
Q3 2024

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$0.04 - $0.13 $17,850 - $58,013	446,258 New	446,258 $31,000
Q1 2023 May 15, 2023	BUY	$0.46 - $0.81 $43,759 - $77,055	95,130 Added 826.36%	106,642 $67,000
Q4 2022 Feb 14, 2023	BUY	$0.5 - $261.0 $5,756 - $3 Million	11,512 New	11,512 $7,000
Q1 2022 May 16, 2022	SELL	$0.62 - $1.17 $81,712 - $154,198	-131,794 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$1.09 - $1.89 $79,583 - $137,992	-73,012 Reduced 35.65%	131,794 $144,000
Q3 2021 Nov 15, 2021	SELL	$1.44 - $2.73 $11,376 - $21,567	-7,900 Reduced 3.71%	204,806 $373,000
Q2 2021 Aug 16, 2021	BUY	$2.63 - $3.67 $70,363 - $98,187	26,754 Added 14.39%	212,706 $562,000
Q1 2021 May 17, 2021	BUY	$2.82 - $5.6 $484,574 - $962,275	171,835 Added 1217.22%	185,952 $669,000
Q4 2020 Feb 16, 2021	SELL	$2.09 - $3.09 $88,112 - $130,271	-42,159 Reduced 74.91%	14,117 $36,000
Q3 2020 Nov 16, 2020	SELL	$2.39 - $3.43 $140,206 - $201,217	-58,664 Reduced 51.04%	56,276 $142,000
Q2 2020 Aug 14, 2020	BUY	$2.2 - $3.71 $252,868 - $426,427	114,940 New	114,940 $377,000
Q1 2020 May 15, 2020	SELL	$1.9 - $4.98 $252,173 - $660,960	-132,723 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$3.95 - $5.35 $428,812 - $580,796	108,560 Added 449.28%	132,723 $626,000
Q3 2019 Nov 14, 2019	BUY	$4.13 - $6.94 $99,793 - $167,691	24,163 New	24,163 $103,000
Q1 2019 May 15, 2019	SELL	$2.0 - $4.4 $66,078 - $145,371	-33,039 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$1.61 - $3.62 $53,192 - $119,601	33,039 New	33,039 $62,000
Q3 2018 Nov 14, 2018	SELL	$2.26 - $3.27 $98,554 - $142,598	-43,608 Closed	0 $0
Q2 2018 Aug 14, 2018	BUY	$3.02 - $4.94 $57,313 - $93,751	18,978 Added 77.05%	43,608 $132,000
Q1 2018 May 15, 2018	BUY	$3.46 - $5.14 $85,219 - $126,598	24,630 New	24,630 $97,000

Others Institutions Holding TCRT

# of Institutions

Shares Held

92.6K

Call Options Held

Put Options Held

View Full List

About Alaunos Therapeutics, Inc.

Ticker TCRT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 216,182,000
Market Cap $493M
Description
Alaunos Therapeutics, Inc., a clinical-stage oncology-focused cell therapy company, develops adoptive TCR engineered T-cell therapies. It develops TCR Library, which is in Phase I/II clinical trial for ten TCRs reactive to mutated KRAS, TP53, and EGFR from its TCR library for the treatment of non-small cell lung, colorectal, endometrial, pancrea...

More about TCRT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Squarepoint Ops LLC, based on Form 13F filings with the SEC.

News

Stay updated on Squarepoint Ops LLC with notifications on news.

Account